Gyrus ACMI allows surgeons to see better and do less tissue damage to their patients. A subsidiary of Olympus, the company makes medical instruments that improve visualization and reduce trauma to tissue during minimally invasive laparoscopic and endoscopic surgeries. It operates through three divisions: Urology & Gynecology, General Surgery, and ENT (ear, nose, and throat). Products range from Invisio digital camera systems to PK workstations used to precisely cut and coagulate tissue. Gyrus ACMI does most of its business in the US, where it maintains a majority of its manufacturing operations and a direct sales force for each division. It also sells through a global network of distributors.
To reach surgical areas beyond its three core specialties, Gyrus ACMI outlicenses its technologies to a number of different medical device companies, including Depuy Mitek (arthroscopy), Guidant (cardiovascular), CONMED (gastrointestinal), and Intuitive Surgical (robotically-assisted surgery). For cosmetic and dermatological procedures, its technology is licensed to Rhytec, a company in which it also holds a minority equity stake. These licensee relationships are grouped together under the company's Partnered Technologies division.
Gyrus ACMI was formerly part of the Gyrus Group, which was acquired by Japan's Olympus in 2008 for nearly $2 billion. It was the largest acquisition in Olympus' history. Although better known by consumers for its cameras, Olympus' scientific and medical businesses have long been a core of its growth. Its endoscope products combined with Gyrus' surgical portfolio positioned it to compete with other top surgical device companies. – less